Tenax Therapeutics, Inc.(TENX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TENX Tenax Therapeutics, Inc.

未开盘 08-12 16:00:00 EDT

1.72

+0.10

+6.17%

盘后1.73

+0.01+0.35%

19:58 EDT

最高1.75	最低1.57	成交量1,254万
今开1.65	昨收1.62	日振幅11.11%
总市值6,437万	流通市值3,013万	总股本3,742万
成交额2,070万	换手率71.60%	流通股本1,752万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TENX","market":"US","secType":"STK","nameCN":"Tenax Therapeutics, Inc.","latestPrice":1.72,"timestamp":1786564800000,"preClose":1.62,"halted":0,"volume":12540865,"hourTrading":{"tag":"盘后","latestPrice":1.726,"preClose":1.72,"latestTime":"19:58 EDT","volume":390277,"amount":671631.9753,"timestamp":1786579127227,"change":0.006,"changeRate":0.003488,"amplitude":0.040814},"delay":0,"changeRate":0.06172839506172831,"floatShares":17515100,"shares":37423900,"eps":-1.468475,"marketStatus":"未开盘","change":0.1,"latestTime":"08-12 16:00:00 EDT","open":1.65,"high":1.75,"low":1.57,"amount":20696268.5169495,"amplitude":0.111111,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.468475,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1786608000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.62,"preHourTrading":{"tag":"盘前","latestPrice":1.6597,"preClose":1.62,"latestTime":"09:29 EDT","volume":294631,"amount":476154.54386569996,"timestamp":1786541387470,"change":0.0397,"changeRate":0.024506,"amplitude":0.08642},"postHourTrading":{"tag":"盘后","latestPrice":1.726,"preClose":1.72,"latestTime":"19:58 EDT","volume":390277,"amount":671631.9753,"timestamp":1786579127227,"change":0.006,"changeRate":0.003488,"amplitude":0.040814},"volumeRatio":0.603013,"impliedVol":1.7026,"impliedVolPercentile":0.4433},"requestUrl":"/m/hq/s/TENX","defaultTab":"news","newsList":[{"id":"1183280522","title":"Tenax与Sionna股价暴跌：临床试验双双失利","url":"https://stock-news.laohu8.com/highlight/detail?id=1183280522","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183280522?lang=zh_cn&edition=full","pubTime":"2026-08-10 22:54","pubTimestamp":1786373686,"startTime":"0","endTime":"0","summary":"周一，生物科技公司Tenax Therapeutics与Sionna Therapeutics的股价遭遇重创，原因在于两家公司先后公布了各自后期临床试验失败的噩耗。Tenax的股价暴跌近90%，其一款针对心力衰竭的实验性药物，在III期临床试验中未能帮助患者行走距离超过安慰剂组。该试验以六分钟步行距离作为标准测试指标——这正是心力衰竭治疗领域的常规衡量标准。此外，另一项评估患者自报症状的试验目标也未能达标。然而，Sionna公司表示，将不再继续推进该药物作为辅助治疗的研发工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TENX","SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116763377","title":"Tenax Therapeutics高管透露：双盲阶段出现两例死亡，调查者判定均与Tnx-103无关——电话会议实录","url":"https://stock-news.laohu8.com/highlight/detail?id=1116763377","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116763377?lang=zh_cn&edition=full","pubTime":"2026-08-10 20:50","pubTimestamp":1786366233,"startTime":"0","endTime":"0","summary":"Tenax Therapeutics高管在电话会议中披露，公司的双盲临床试验阶段发生了两例死亡事件。然而，调查人员经过审慎评估后确认，这两起死亡与试验药物Tnx-103并无关联。这一信息来自公司内部的电话会议陈述，投资者对此高度关注。高管强调，药物安全性仍是首要考量，而独立调查结果提供了关键支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TENX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141240687","title":"Orion宣布：合作伙伴Tenax的临床试验未达主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1141240687","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1141240687?lang=zh_cn&edition=full","pubTime":"2026-08-10 19:23","pubTimestamp":1786361022,"startTime":"0","endTime":"0","summary":"Orion Oyj 旗下授权合作伙伴Tenax Therapeutics的3期临床试验未能达到其主要终点。该试验是一项针对口服左西孟旦在射血分数保留的心力衰竭合并肺动脉高压（PH-HFPEF）患者中的3期临床研究。Tenax计划向美国食品药品监督管理局申请会议，讨论修订当前左西孟旦用于治疗PH-HFPEF的注册性开发方案。同时，Tenax也将寻求欧洲药品管理局的平行科学咨询意见。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TENX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189920882","title":"Tenax Therapeutics第二季度净亏损1780.3万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1189920882","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189920882?lang=zh_cn&edition=full","pubTime":"2026-07-31 19:16","pubTimestamp":1785496616,"startTime":"0","endTime":"0","summary":"Tenax Therapeutics第二季度运营支出达1878.4万美元。该公司净亏损1780.3万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TENX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149927640","title":"Tenax Therapeutics 将于2026年ESC大会上作最新临床试验数据报告","url":"https://stock-news.laohu8.com/highlight/detail?id=1149927640","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149927640?lang=zh_cn&edition=full","pubTime":"2026-07-02 19:00","pubTimestamp":1782990048,"startTime":"0","endTime":"0","summary":"Tenax Therapeutics, Inc. (TENX) 宣布，其一项关键临床试验的数据报告，已被选为2026年欧洲心脏病学会大会的晚场突破性报告。这一入选标志着该公司在心血管治疗领域的研究进展获得了国际顶级学术会议的认可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TENX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130013839","title":"Tenax Therapeutics 通过第六次修正案将美国监管批准截止日期延长至2035年12月31日","url":"https://stock-news.laohu8.com/highlight/detail?id=1130013839","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1130013839?lang=zh_cn&edition=full","pubTime":"2026-07-01 04:38","pubTimestamp":1782851891,"startTime":"0","endTime":"0","summary":"Tenax Therapeutics, Inc. 已通过对其与Orion公司许可协议的第六次修正案，将美国监管批准的最后期限延长至2035年12月31日。此项延期事宜已根据美国证券交易委员会（SEC）的规定提交了相关文件。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TENX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195698525","title":"Tenax Therapeutics一季度净亏损1571.6万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1195698525","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195698525?lang=zh_cn&edition=full","pubTime":"2026-05-12 19:16","pubTimestamp":1778584572,"startTime":"0","endTime":"0","summary":"Tenax Therapeutics公布的第一季度财务数据显示，公司净亏损达到1571.6万美元。同期，其运营支出为1657.3万美元，这一数字是导致其净亏损的主要因素。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TENX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100833246","title":"Tenax Therapeutics公布2025年第四季度及全年财报并更新企业动态","url":"https://stock-news.laohu8.com/highlight/detail?id=1100833246","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100833246?lang=zh_cn&edition=full","pubTime":"2026-03-10 19:04","pubTimestamp":1773140675,"startTime":"0","endTime":"0","summary":"Tenax Therapeutics, Inc.（简称Tenax）近日披露了2025年第四季度及全年的财务业绩报告，同时向市场同步了公司最新的战略进展与运营动态。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TENX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517978791","title":"Tenax Therapeutics, Inc.盘中异动 股价大跌5.14%报5.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517978791","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517978791?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:45","pubTimestamp":1741290354,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时45分，Tenax Therapeutics, Inc.股票出现波动，股价急速下挫5.14%。Tenax Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.61%。Tenax Therapeutics, Inc.公司简介：Tenax Therapeutics Inc是一家专业制药公司，致力于识别、开发和商业化，解决那些盖度未满足医疗需求的心血管疾病和肺部疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307034555963c8303&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307034555963c8303&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","TENX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517943946","title":"Tenax Therapeutics, Inc.盘中异动 早盘快速拉升5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517943946","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517943946?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185115,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分，Tenax Therapeutics, Inc.股票出现波动，股价大幅上涨5.11%。Tenax Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Tenax Therapeutics, Inc.公司简介：Tenax Therapeutics Inc是一家专业制药公司，致力于识别、开发和商业化，解决那些盖度未满足医疗需求的心血管疾病和肺部疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223155989d45eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223155989d45eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TENX","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517028756","title":"Tenax Therapeutics, Inc.盘中异动 急速拉升6.42%报6.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517028756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517028756?lang=zh_cn&edition=full","pubTime":"2025-03-05 01:43","pubTimestamp":1741110217,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日01时43分，Tenax Therapeutics, Inc.股票出现异动，股价大幅拉升6.42%。截至发稿，该股报6.06美元/股，成交量8002股，换手率0.23%，振幅6.06%。Tenax Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。Tenax Therapeutics, Inc.公司简介：Tenax Therapeutics Inc是一家专业制药公司，致力于识别、开发和商业化，解决那些盖度未满足医疗需求的心血管疾病和肺部疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305014337989bdaf3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305014337989bdaf3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","TENX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516513632","title":"Tenax Therapeutics, Inc.盘中异动 股价大涨8.44%报6.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516513632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516513632?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:48","pubTimestamp":1741013322,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时48分，Tenax Therapeutics, Inc.股票出现异动，股价急速拉升8.44%。Tenax Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Tenax Therapeutics, Inc.公司简介：Tenax Therapeutics Inc是一家专业制药公司，致力于识别、开发和商业化，解决那些盖度未满足医疗需求的心血管疾病和肺部疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224842989a1472&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224842989a1472&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","TENX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514016645","title":"Tenax Therapeutics, Inc.盘中异动 早盘股价大跌5.26%报5.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514016645","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514016645?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:38","pubTimestamp":1740497897,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时38分，Tenax Therapeutics, Inc.股票出现异动，股价大幅跳水5.26%。Tenax Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。Tenax Therapeutics, Inc.公司简介：Tenax Therapeutics Inc是一家专业制药公司，致力于识别、开发和商业化，解决那些盖度未满足医疗需求的心血管疾病和肺部疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233818abdc8f1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233818abdc8f1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","TENX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514081387","title":"Tenax Therapeutics, Inc.盘中异动 快速下挫7.63%报6.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514081387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514081387?lang=zh_cn&edition=full","pubTime":"2025-02-25 03:56","pubTimestamp":1740427005,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日03时56分，Tenax Therapeutics, Inc.股票出现异动，股价大幅下挫7.63%。Tenax Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。其相关个股中，Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为325.25%、139.69%、40.20%，振幅较大的相关个股有Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为176.22%、162.04%、81.92%。Tenax Therapeutics, Inc.公司简介：Tenax Therapeutics Inc是一家专业制药公司，致力于识别、开发和商业化，解决那些盖度未满足医疗需求的心血管疾病和肺部疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225035645abdb5288&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225035645abdb5288&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TENX","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513291791","title":"Tenax Therapeutics, Inc.盘中异动 急速拉升5.23%报6.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513291791","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513291791?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:31","pubTimestamp":1740148264,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时31分，Tenax Therapeutics, Inc.股票出现波动，股价快速拉升5.23%。Tenax Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Tenax Therapeutics, Inc.公司简介：Tenax Therapeutics Inc是一家专业制药公司，致力于识别、开发和商业化，解决那些盖度未满足医疗需求的心血管疾病和肺部疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223104962b7b1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223104962b7b1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","TENX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512434303","title":"Tenax Therapeutics, Inc.盘中异动 股价大跌5.37%报6.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512434303","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512434303?lang=zh_cn&edition=full","pubTime":"2025-02-20 04:58","pubTimestamp":1739998696,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日04时58分，Tenax Therapeutics, Inc.股票出现异动，股价快速跳水5.37%。截至发稿，该股报6.69美元/股，成交量5.7044万股，换手率1.67%，振幅8.20%。Tenax Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。Tenax Therapeutics, Inc.公司简介：Tenax Therapeutics Inc是一家专业制药公司，致力于识别、开发和商业化，解决那些盖度未满足医疗需求的心血管疾病和肺部疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220045816a24c3fa1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220045816a24c3fa1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TENX","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510333011","title":"Tenax Therapeutics, Inc.盘中异动 早盘大幅下挫6.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510333011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510333011?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:26","pubTimestamp":1739287570,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时26分，Tenax Therapeutics, Inc.股票出现异动，股价急速下跌6.57%。Tenax Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.61%。Tenax Therapeutics, Inc.公司简介：Tenax Therapeutics Inc是一家专业制药公司，致力于识别、开发和商业化，解决那些盖度未满足医疗需求的心血管疾病和肺部疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211232610abcb124f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211232610abcb124f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","TENX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510914862","title":"Tenax Therapeutics, Inc.盘中异动 快速上涨5.42%报7.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510914862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510914862?lang=zh_cn&edition=full","pubTime":"2025-02-11 00:27","pubTimestamp":1739204828,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日00时27分，Tenax Therapeutics, Inc.股票出现异动，股价大幅拉升5.42%。Tenax Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Tenax Therapeutics, Inc.公司简介：Tenax Therapeutics Inc是一家专业制药公司，致力于识别、开发和商业化，解决那些盖度未满足医疗需求的心血管疾病和肺部疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021100270898808eb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021100270898808eb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TENX","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509209015","title":"Tenax Therapeutics, Inc.盘中异动 股价大涨5.11%报6.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509209015","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509209015?lang=zh_cn&edition=full","pubTime":"2025-02-07 00:56","pubTimestamp":1738860989,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日00时56分，Tenax Therapeutics, Inc.股票出现波动，股价急速拉升5.11%。Tenax Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Tenax Therapeutics, Inc.公司简介：Tenax Therapeutics Inc是一家专业制药公司，致力于识别、开发和商业化，解决那些盖度未满足医疗需求的心血管疾病和肺部疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207005630987ca4f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207005630987ca4f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TENX","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509822782","title":"Tenax Therapeutics, Inc.盘中异动 快速拉升8.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509822782","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509822782?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:31","pubTimestamp":1738765910,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时31分，Tenax Therapeutics, Inc.股票出现异动，股价大幅上涨8.42%。Tenax Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。Tenax Therapeutics, Inc.公司简介：Tenax Therapeutics Inc是一家专业制药公司，致力于识别、开发和商业化，解决那些盖度未满足医疗需求的心血管疾病和肺部疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223150a23a7a70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223150a23a7a70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","TENX"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tenaxthera.com","stockEarnings":[{"period":"1week","weight":-0.8682},{"period":"1month","weight":-0.8924},{"period":"3month","weight":-0.8555},{"period":"6month","weight":-0.864},{"period":"1year","weight":-0.708},{"period":"ytd","weight":-0.8589}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":0.0311},{"period":"3month","weight":0.0325},{"period":"6month","weight":0.1331},{"period":"1year","weight":0.202},{"period":"ytd","weight":0.1328}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tenax Therapeutics, Inc.最初于1967年以Rudmer, David & Associates, Inc.的名义成立为新泽西州公司，随后更名为Synthetic Blood International, Inc.。自2008年6月30日起，该公司将公司的注册地改为特拉华州并更名为Oxygen Biotherapeutics, Inc.。2014年9月19日，该公司更名为Tenax Therapeutics, Inc.。该公司是一家专业制药公司，专注于识别、开发和商业化产品，以解决医疗需求未得到满足的心血管和肺部疾病。该公司的主要业务目标是代表临床需求和商业机会的重要领域的疾病适应症识别、开发和商业化新型治疗产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.174007},{"month":2,"riseRate":0.166667,"avgChangeRate":-0.128329},{"month":3,"riseRate":0.416667,"avgChangeRate":0.025378},{"month":4,"riseRate":0.272727,"avgChangeRate":-0.034902},{"month":5,"riseRate":0.363636,"avgChangeRate":0.065949},{"month":6,"riseRate":0.583333,"avgChangeRate":-0.020009},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.003191},{"month":8,"riseRate":0.25,"avgChangeRate":-0.116321},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.018463},{"month":10,"riseRate":0.416667,"avgChangeRate":-0.070479},{"month":11,"riseRate":0.583333,"avgChangeRate":0.07352},{"month":12,"riseRate":0.666667,"avgChangeRate":0.039185}],"exchange":"NASDAQ","name":"Tenax Therapeutics, Inc.","nameEN":"Tenax Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tenax Therapeutics, Inc.(TENX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tenax Therapeutics, Inc.(TENX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tenax Therapeutics, Inc.,TENX,Tenax Therapeutics, Inc.股票,Tenax Therapeutics, Inc.股票老虎,Tenax Therapeutics, Inc.股票老虎国际,Tenax Therapeutics, Inc.行情,Tenax Therapeutics, Inc.股票行情,Tenax Therapeutics, Inc.股价,Tenax Therapeutics, Inc.股市,Tenax Therapeutics, Inc.股票价格,Tenax Therapeutics, Inc.股票交易,Tenax Therapeutics, Inc.股票购买,Tenax Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tenax Therapeutics, Inc.(TENX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tenax Therapeutics, Inc.(TENX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}